These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27339591)

  • 21. Insulin-related lipohypertrophy: ultrasound characteristics, risk factors, and impact of glucose fluctuations.
    Lin Y; Lin L; Wang W; Hong J; Zeng H
    Endocrine; 2022 Mar; 75(3):768-775. PubMed ID: 34648113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Injection site lipoatrophy: a rare complication of recombinant human insulin.
    Chakraborty PP; Bhattacharjee R
    J Assoc Physicians India; 2010 Oct; 58():630. PubMed ID: 21510114
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors.
    Hauner H; Stockamp B; Haastert B
    Exp Clin Endocrinol Diabetes; 1996; 104(2):106-10. PubMed ID: 8740933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Effective Intervention for Diabetic Lipohypertrophy: Results of a Randomized, Controlled, Prospective Multicenter Study in France.
    Campinos C; Le Floch JP; Petit C; Penfornis A; Winiszewski P; Bordier L; Lepage M; Fermon C; Louis J; Almain C; Morel D; Hirsch L; Strauss KW
    Diabetes Technol Ther; 2017 Nov; 19(11):623-632. PubMed ID: 29058477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A meta-analysis and meta-regression on the prevalence of lipohypertrophy in diabetic patients on insulin therapy.
    Wang K; Zhang S; Liu C; Chen Y
    Therapie; 2021; 76(6):617-628. PubMed ID: 33958198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of Insulin Injection Technique: Examination of Current Issues and Recommendations.
    Spollett G; Edelman SV; Mehner P; Walter C; Penfornis A
    Diabetes Educ; 2016 Aug; 42(4):379-94. PubMed ID: 27216036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Worldwide Injection Technique Questionnaire Study: Injecting Complications and the Role of the Professional.
    Frid AH; Hirsch LJ; Menchior AR; Morel DR; Strauss KW
    Mayo Clin Proc; 2016 Sep; 91(9):1224-30. PubMed ID: 27594186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-induced lipohypertrophy: report of a case with histopathology.
    Fujikura J; Fujimoto M; Yasue S; Noguchi M; Masuzaki H; Hosoda K; Tachibana T; Sugihara H; Nakao K
    Endocr J; 2005 Oct; 52(5):623-8. PubMed ID: 16284443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combination treatment with insulin and metformin in type 2 diabetes. Improves glycemic control and prevents weight gain].
    Hermann LS; Melander A
    Lakartidningen; 1999 Dec; 96(50):5616-9. PubMed ID: 10643226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes.
    Gentile S; Guarino G; Della Corte T; Marino G; Fusco A; Corigliano G; Colarusso S; Piscopo M; Improta MR; Corigliano M; Martedi E; Oliva D; Russo V; Simonetti R; Satta E; Romano C; Vaia S; Strollo F; ;
    Diabetes Ther; 2021 Jan; 12(1):107-119. PubMed ID: 33219928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Worldwide Injection Technique Questionnaire Study: Population Parameters and Injection Practices.
    Frid AH; Hirsch LJ; Menchior AR; Morel DR; Strauss KW
    Mayo Clin Proc; 2016 Sep; 91(9):1212-23. PubMed ID: 27594185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2).
    Zinman B; Marso SP; Poulter NR; Emerson SS; Pieber TR; Pratley RE; Lange M; Brown-Frandsen K; Moses A; Ocampo Francisco AM; Barner Lekdorf J; Kvist K; Buse JB;
    Diabetologia; 2018 Jan; 61(1):48-57. PubMed ID: 28913575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.
    Ritsinger V; Malmberg K; Mårtensson A; Rydén L; Wedel H; Norhammar A
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):627-33. PubMed ID: 24831989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
    André P
    Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683
    [No Abstract]   [Full Text] [Related]  

  • 35. Metformin: diamonds are forever.
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double-blind and cross-over trial.
    Perriello G; Pampanelli S; Porcellati F; Avogaro A; Bosi E; Petrella G; Squatrito S; Furneri S; Marra G; Vitali L; Previti M; Cucinotta D
    Diabet Med; 2005 May; 22(5):606-11. PubMed ID: 15842516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early detection of cutaneous complications of insulin therapy in type 1 and type 2 diabetes mellitus.
    Arora S; Agrawal NK; Shanthaiah DM; Verma A; Singh S; Patne SCU; Kalra S; Singh P; Goyal S
    Prim Care Diabetes; 2021 Oct; 15(5):859-864. PubMed ID: 34154931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type 2 diabetes - controlling hyperglycaemia with early insulin use.
    MacIsaac R; Cheung A; Jerums G
    Aust Fam Physician; 2010 Aug; 39(8):565-9. PubMed ID: 20877750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between the extent of urinary albumin excretion and glycaemic variability indices measured by continuous glucose monitoring.
    Jin SM; Kim TH; Oh S; Baek J; Joung JY; Park SM; Cho YY; Sohn SY; Hur KY; Lee MS; Lee MK; Kim JH
    Diabet Med; 2015 Feb; 32(2):274-9. PubMed ID: 25307609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postprandial glycaemic effects of a long-acting somatostatin analogue (octreotide) in non-insulin dependent diabetes mellitus.
    Williams G; Füessl HS; Burrin JM; Chilvers E; Bloom SR
    Horm Metab Res; 1988 Mar; 20(3):168-70. PubMed ID: 2898427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.